ROSHANDA WASHINGTON: Open Payments
NPI 1205500261 · MARKSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 25 payments from 7 companies in 2025. Trend: 2023 $232 · 2024 $318 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $276 |
| Axsome Therapeutics, Inc. | 7 | $274 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $52 |
| Tris Pharma Inc | 3 | $46 |
| Lilly USA, LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: Qelbree, Auvelity, REXULTI, VRAYLAR, Dyanavel XR, JARDIANCE, CAPLYTA, MOUNJARO.
Industry payments across LA — which companies pay providers there.
